Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- How Real founder Ariela Safira drew from past experiences to build the mental health startup;
- See the presentation microbiome startup Seed Health used to raise $40 million;
- 2 healthcare startups have a plan to simplify the digital health boom.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…
Courtesy of Real
A Cityblock alum raised $10 million for her app taking a preventive, group therapy approach to mental health
- Real, a consumer mental health startup "building for preventive care," raised $10 million in April.
- Its founder, a Cityblock alum and Columbia clinical psychology dropout, said Real has no plans to work with insurers.
- Current mental health provider training is outdated, she says, with no capacity to offer "focused" care.
Here's a look at what Real's up to>>
Ara Katz, left, and Raja Dhir, cofounder Seed Health in 2015 to extend the young microbiome field past applications in the gut.
Seed Health
Seed Health
Seed Health wants to use bacteria to stop premature births and curb plastic waste. We got a peek at the slides it used to raise $40 million.
- Microbiome startup Seed Health has raised $40 million from Founders Fund, 8VC and others.
- The Series A round values the company at around $200 million, according to a company executive.
- The biotech is developing products that use good bacteria to address health issues and the environment.
Hinge Health
A cost-saving healthcare startup is tapping Hinge to simplify the digital health boom for big companies
- Carrum and Hinge Health are teaming up to simplify benefits for big companies.
- Carrum's CEO said that large employers have too many options and are looking to bundle offerings.
- Hinge customers can access Carrum's surgery cost-bundling service at no extra cost, and vice versa.
More stories we're reading:
- Watch: Insider answers your questions about the risk of rare but serious blood clots following some COVID-19 vaccines (Insider)
- The family that owns OxyContin-maker Purdue Pharma are worth $11 billion (The Wall Street Journal)
- The FDA cited the vaccine plant that ruined millions of Johnson & Johnson doses for unsanitary conditions, finding 'brown residue' on the walls and peeling paint (Insider)
- The US is set to run out of adults who are excited to get vaccines in the next 2-4 weeks (Axios)
- Lydia
Read the original article on Business Insider
